
Jagsonpal
JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited Price (JAGSNPHARM.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
66,299,167
(1.2278)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Jagsonpal Pharmaceuticals LimitedCurrency: INR
YEAR | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
1,500,939,872.00
+0% |
1,361,976,157.00
-9% |
1,395,934,054.00
+2% |
1,609,549,785.00
+15% |
1,765,139,000.00
+10% |
1,664,645,000.00
-6% |
1,438,509,000.00
-14% |
1,381,509,000.00
-4% |
1,434,879,000.00
+4% |
1,438,704,000.00
+0% |
1,265,329,000.00
-12% |
1,668,256,000.00
+32% |
1,585,678,000.00
-5% |
1,878,756,000.00
+18% |
2,260,967,000.00
+20% |
2,367,141,000.00
+5% |
2,087,020,000.00
-12% |
||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 913,058,099.00 | 789,031,556.00 | 755,022,604.00 | 830,001,648.00 | 845,459,000.00 | 861,622,000.00 | 647,060,000.00 | 686,829,000.00 | 591,233,000.00 | 589,497,000.00 | 612,945,000.00 | 729,321,000.00 | 562,311,000.00 | 809,340,000.00 | 961,057,000.00 | 931,039,000.00 | 1,434,430,000.00 | ||
Gross Profit | |||||||||||||||||||
Gross Profit |
587,881,773.00
+0% |
572,944,601.00
-3% |
640,911,450.00
+12% |
779,548,137.00
+22% |
919,680,000.00
+18% |
803,023,000.00
-13% |
791,449,000.00
-1% |
694,680,000.00
-12% |
843,646,000.00
+21% |
849,207,000.00
+1% |
652,384,000.00
-23% |
938,935,000.00
+44% |
1,023,367,000.00
+9% |
1,069,416,000.00
+4% |
1,299,910,000.00
+22% |
1,436,102,000.00
+10% |
652,590,000.00
-55% |
||
Gross Profit Ratio | (0.39%) | (0.42%) | (0.46%) | (0.48%) | (0.52%) | (0.48%) | (0.55%) | (0.50%) | (0.59%) | (0.59%) | (0.52%) | (0.56%) | (0.65%) | (0.57%) | (0.58%) | (0.61%) | (0.31%) | ||
Operating Expenses | |||||||||||||||||||
Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6,933,000.00 | 5,548,000.00 | 3,285,000.00 | 4,688,000.00 | 5,644,000.00 | 3,743,000.00 | 1,209,000.00 | 1,541,000.00 | 3,458,000.00 | 0.00 | 0.00 | 0.00 | ||
General and Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 400,000.00 | 452,000.00 | 0.00 | 93,719,000.00 | 0.00 | 6,930,000.00 | 14,965,000.00 | 8,968,000.00 | 40,694,000.00 | 101,728,000.00 | 57,640,000.00 | 38,050,000.00 | ||
Selling, General & Admin... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 615,012,000.00 | 604,959,000.00 | 334,233,000.00 | 203,674,000.00 | 345,635,000.00 | 119,387,000.00 | 146,942,000.00 | 187,414,000.00 | 170,595,000.00 | 254,903,000.00 | 243,720,000.00 | 438,550,000.00 | ||
Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38,262,000.00 | 38,547,000.00 | 0.00 | 109,955,000.00 | 0.00 | 112,457,000.00 | 131,977,000.00 | 178,446,000.00 | 129,901,000.00 | 153,175,000.00 | 186,080,000.00 | 163,360,000.00 | ||
Depreciation and Amortiz... | 16,872,231.00 | 12,498,276.00 | 20,849,811.00 | 22,008,864.00 | 25,358,000.00 | 27,076,000.00 | 28,254,000.00 | 27,069,000.00 | 30,936,000.00 | 19,940,000.00 | 3,198,000.00 | 10,158,000.00 | 11,298,000.00 | 10,860,000.00 | 15,260,000.00 | 11,750,000.00 | 16,630,000.00 | ||
Other Expenses | 472,449,561.00 | 428,166,394.00 | 500,948,086.00 | 653,649,050.00 | 3,214,000.00 | 2,911,000.00 | 15,000.00 | 633,378,000.00 | 1,000.00 | 808,036,000.00 | 646,058,000.00 | 1,321,000.00 | 758,188,000.00 | 3,565,000.00 | 1,777,000.00 | 57,339,000.00 | 0.00 | ||
Total Operating Expenses | 472,449,561.00 | 428,166,394.00 | 500,948,086.00 | 653,649,050.00 | 778,891,000.00 | 729,556,000.00 | 712,924,000.00 | 633,378,000.00 | 750,561,000.00 | 808,036,000.00 | 765,445,000.00 | 854,421,000.00 | 945,602,000.00 | 881,552,000.00 | 1,052,360,000.00 | 1,106,639,000.00 | 438,550,000.00 | ||
Cost and Exponses | 1,385,507,660.00 | 1,217,197,950.00 | 1,255,970,690.00 | 1,483,650,698.00 | 1,624,350,000.00 | 1,591,178,000.00 | 1,359,984,000.00 | 1,320,207,000.00 | 1,341,794,000.00 | 1,397,533,000.00 | 1,378,390,000.00 | 1,583,742,000.00 | 1,507,913,000.00 | 1,690,892,000.00 | 2,013,417,000.00 | 2,037,678,000.00 | 1,866,780,000.00 | ||
Operating Income | |||||||||||||||||||
Operating Income |
51,918,579.00
+0% |
98,985,230.00
+91% |
105,000,977.00
+6% |
92,681,268.00
-12% |
97,685,000.00
+5% |
22,451,000.00
-77% |
25,298,000.00
+13% |
16,717,000.00
-34% |
40,752,000.00
+144% |
143,967,000.00
+253% |
-111,265,000.00
-177% |
83,193,000.00
-175% |
74,027,000.00
-11% |
187,864,000.00
+154% |
239,870,000.00
+28% |
338,850,000.00
+41% |
214,040,000.00
-37% |
||
Operating Income Ratio | (0.03%) | (0.07%) | (0.08%) | (0.06%) | (0.06%) | (0.01%) | (0.02%) | (0.01%) | (0.03%) | (0.10%) | (-0.09%) | (0.05%) | (0.05%) | (0.10%) | (0.11%) | (0.14%) | (0.10%) | ||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 0.00 | 0.00 | 0.00 | 325,000.00 | 475,000.00 | 319,000.00 | 592,000.00 | 130,000.00 | 634,000.00 | 1,261,000.00 | 3,362,000.00 | 12,967,000.00 | 21,680,000.00 | 29,924,000.00 | 15,456,000.00 | 34,280,000.00 | 85,920,000.00 | ||
Interest Expenses | 63,513,633.00 | 45,792,977.00 | 34,962,387.00 | 33,217,819.00 | 43,582,000.00 | 51,335,000.00 | 53,819,000.00 | 44,585,000.00 | 51,071,000.00 | 25,029,000.00 | 5,002,000.00 | 4,443,000.00 | 3,831,000.00 | 4,275,000.00 | 2,608,000.00 | 4,127,000.00 | 8,140,000.00 | ||
Total Other Income/Exp... | -57,283,521.00 | -39,449,980.00 | -31,332,323.00 | -30,615,966.00 | -40,040,000.00 | -48,181,000.00 | -53,331,000.00 | -44,454,000.00 | -52,333,000.00 | 104,281,000.00 | -3,206,000.00 | 5,514,000.00 | 20,121,000.00 | 30,859,000.00 | 20,970,000.00 | 9,230,000.00 | 84,650,000.00 | ||
EBITDA | |||||||||||||||||||
EBITDA | 128,624,441.00 | 153,639,536.00 | 160,813,171.00 | 147,907,950.00 | 169,839,000.00 | 103,774,000.00 | 107,386,000.00 | 88,372,000.00 | 124,659,000.00 | 190,355,000.00 | -103,406,000.00 | 107,641,000.00 | 110,587,000.00 | 234,718,000.00 | 284,530,000.00 | 363,960,000.00 | 323,460,000.00 | ||
EBITDA ratio | (0.09%) | (0.12%) | (0.12%) | (0.09%) | (0.09%) | (0.06%) | (0.07%) | (0.06%) | (0.09%) | (0.04%) | (-0.08%) | (0.06%) | (0.07%) | (0.12%) | (0.12%) | (0.17%) | (0.15%) | ||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 51,918,579.00 | 98,985,230.00 | 105,000,977.00 | 92,681,268.00 | 100,899,000.00 | 25,363,000.00 | 25,313,000.00 | 16,717,000.00 | 40,753,000.00 | 143,967,000.00 | -116,267,000.00 | 90,028,000.00 | 94,148,000.00 | 218,723,000.00 | 273,191,000.00 | 348,085,000.00 | 298,690,000.00 | ||
Income Before Tax Ratio | (0.03%) | (0.07%) | (0.08%) | (0.06%) | (0.06%) | (0.02%) | (0.02%) | (0.01%) | (0.03%) | (0.10%) | (-0.09%) | (0.05%) | (0.06%) | (0.12%) | (0.12%) | (0.15%) | (0.14%) | ||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 21,158,180.00 | 37,262,351.00 | 12,581,383.00 | 20,884,832.00 | 26,330,000.00 | 7,036,000.00 | 4,106,000.00 | 5,006,000.00 | 8,211,000.00 | 25,320,000.00 | -761,000.00 | 17,867,000.00 | 15,440,000.00 | 48,140,000.00 | 77,321,000.00 | 80,872,000.00 | 74,060,000.00 | ||
Net Income | |||||||||||||||||||
Net Income | 30,760,399.00
+0% |
61,722,879.00
+101% |
92,419,594.00
+50% |
71,796,436.00
-22% |
74,568,000.00
+4% |
18,327,000.00
-75% |
21,207,000.00
+16% |
11,711,000.00
-45% |
32,542,000.00
+178% |
118,647,000.00
+265% |
-115,506,000.00
-197% |
72,161,000.00
-162% |
78,708,000.00
+9% |
170,583,000.00
+117% |
188,550,000.00
+11% |
267,210,000.00
+42% |
224,630,000.00
-16% |
||
Net Income Ratio | (0.02%) | (0.05%) | (0.07%) | (0.04%) | (0.04%) | (0.01%) | (0.01%) | (0.01%) | (0.02%) | (0.08%) | (-0.09%) | (0.04%) | (0.05%) | (0.09%) | (0.08%) | (0.11%) | (0.11%) | ||
Earning Per Share | |||||||||||||||||||
Basic EPS | 1.17 | 2.35 | 3.76 | 2.74 | 2.85 | 0.70 | 0.81 | 0.45 | 1.24 | 4.53 | -4.41 | 2.75 | 3.00 | 6.51 | 7.20 | 10.20 | 8.46 | ||
Diluted EPS | 1.17 | 2.35 | 3.76 | 2.74 | 2.85 | 0.70 | 0.81 | 0.45 | 1.24 | 4.53 | -4.41 | 2.75 | 3.00 | 6.51 | 7.20 | 10.20 | 3.39 | ||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,453,702.50 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,479,590.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 66,380,022.50 | ||
Diluted Share Outstanding | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,453,702.50 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 65,495,000.00 | 66,299,167.00 |